Starling
YC W22Houston, US · Founded 2019 · Delaware corporation · 5 employees · Hiring · 13 known investors
Starling Medical develops smart devices and predictive learning solutions focused on preventative bladder health and urinary tract infection management. The company combines digital health technology with clinical analytics to augment standard UTI care.
Also known as Starling Medical
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesMachine LearningUnited States of AmericaAmerica / CanadaPartly Remote
Founders & leadership· Y Combinator alumni (W22)
Starling was founded in 2019 by Drew Hendricks and Hannah McKenney.
DH
Drew HendricksinCo-founder · Director of Clinical StrategyDrew Hendricks holds a medical background and has experience in medical device design. He is developing health-tech solutions focused on diagnostics at Starling.
HM
Hannah McKenneyinCo-founder · Chief Executive OfficerHannah McKenney has worked in both clinical hospital and industry settings, developing expertise in human-centered design and usability of medical technologies. She focuses on problem definition, product development, and implementation of medical device and digital health solutions.
Board
Investors · 13
Pixel Perfect VenturesWashington DC
Y CombinatorSan Francisco · $500K
ExpareportedWest Hollywood · $250K – $3M
Fidelity InvestmentsreportedBoston
Magnify VenturesreportedSanta Monica · $250K – $2M
Pear VCreportedSan Francisco · $150K – $4M
Rethink ImpactreportedWashington · $2M – $10M
Ulu VenturesreportedPalo Alto · $2M
Zeal Capital PartnersreportedWashington · $250K – $2M
Also in the syndicate · 4
Fiore VenturesGraham & WalkerRogue Women's Fundthe March of Dimes
Reported raises · per SEC filings
Form D private placements$9.7M disclosed across 2 of 3 rounds · 2024–2026
▶$825KraisedMar 2026 · 5 investors · BiotechnologyRule 506(b)
▶$825KraisedMar 2026 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William Andrew HendricksDirector
- Hannah McKenneyExecutive Officer, Director
- Kunj ShethDirector
- Shana BarghoutiDirector
- William HagamanDirector
- Offering amount
- $1.8M
- Amount sold
- $825K
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.9MraisedDec 2024 · 40 investors · BiotechnologyRule 506(b)
▶$8.9MraisedDec 2024 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Shana BarghoutiDirector
- Kunj ShethDirector
- Hannah McKenneyExecutive Officer, Director
- William Andrew HendricksDirector
- Offering amount
- $8.9M
- Amount sold
- $8.9M
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlap
Companies competing with Starling for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Starling Bank to axe 130 jobs - Tech.eutech.eu · Jul 2026
Starling Bank to cut 130 jobs and boost investment in AI to reduce costs | Starling Bank | The Guardiantheguardian.com · Jul 2026Frequently asked questions
- What does Starling do?
- Starling Medical develops smart devices and predictive learning solutions focused on preventative bladder health and urinary tract infection management. The company combines digital health technology with clinical analytics to augment standard UTI care.
- Who founded Starling?
- Starling was founded by Drew Hendricks, Hannah McKenney in 2019.
- Who are Starling's investors?
- Starling's investors include Pixel Perfect Ventures, Y Combinator, Expa, Fidelity Investments, Magnify Ventures, Pear VC, Rethink Impact, Ulu Ventures and 1 more.
- How much funding has Starling raised?
- Starling has disclosed $9.7M raised across 2 of its 3 known rounds.
- Where is Starling headquartered?
- Starling is headquartered in Houston, US.